Sun Pharma latest to sell COVID-19 drug favipiravir in India

This post was originally published on this site

BENGALURU (Reuters) – India’s Sun Pharmaceutical Industries Ltd said on Tuesday it would soon begin selling its version of favipiravir, becoming the latest generic drugmaker to supply the antiviral to treat COVID-19 in the world’s third worst-hit nation.

Click here to read full article